Express Scripts Holding Co. (ESRX)

94.58
NASDAQ : Health Services
Prev Close 95.04
Day Low/High 94.48 / 95.51
52 Wk Low/High 55.80 / 96.45
Avg Volume 4.04M
Exchange NASDAQ
Shares Outstanding 562.23M
Market Cap 53.43B
EPS 7.80
Div & Yield N.A. (N.A)
Tilray Shares Go Crazy; Healthcare Services M&A to Remain Strong -- ICYMI

Tilray Shares Go Crazy; Healthcare Services M&A to Remain Strong -- ICYMI

Here's what you need to know for Wednesday, Sept. 18.

Express Scripts Earns Highest Overall Customer Satisfaction Rating According To Independent Survey Of Plan Sponsors

Express Scripts Earns Highest Overall Customer Satisfaction Rating According To Independent Survey Of Plan Sponsors

The Pharmacy Benefit Management Institute (PBMI) 2018 survey ranks Express Scripts at the top of pharmacy benefit managers (PBMs) in overall satisfaction

The New #34 Most Shorted Nasdaq 100 Component: Express Scripts Holding

The New #34 Most Shorted Nasdaq 100 Component: Express Scripts Holding

The most recent short interest data has been released for the 08/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Dow Closes Higher; Techs Slide

Dow Closes Higher; Techs Slide

Stocks are mixed on Thursday as investors brace for another potentially damaging escalation in the ongoing trade war between the U.S. and China.

CVS and Aetna, CBS, American Express, Papa John's - 5 Things You Must Know

CVS and Aetna, CBS, American Express, Papa John's - 5 Things You Must Know

U.S. stock futures rise slightly as investors brace for a potentially damaging escalation in U.S. and China trade war; the Justice Department is reportedly close to giving the green light to two mega deals in the healthcare sector; CBS and National Amusements are in settlement talks, a report says.

Enticing Investments on the Eve of NFL; Activist Mold M&A Landscape -- ICYMI

Enticing Investments on the Eve of NFL; Activist Mold M&A Landscape -- ICYMI

Here's what you need to know now for Wednesday, Sept. 5.

Inside Rx® Prescription Savings Card Boosts Deep Discounts On Brand-Name Medications To More Than 130 Drugs

Inside Rx® Prescription Savings Card Boosts Deep Discounts On Brand-Name Medications To More Than 130 Drugs

Inside Rx has provided patients with $160 million in savings on brand and generic medications since its inception in May 2017

Express Scripts Stockholders Approve Acquisition By Cigna

Express Scripts Stockholders Approve Acquisition By Cigna

ST. LOUIS, Aug.

Express Scripts Reminds Stockholders To Vote "FOR" The Merger With Cigna

Express Scripts Reminds Stockholders To Vote "FOR" The Merger With Cigna

Special Meeting of Stockholders to Vote on the Transaction to be held on Friday, August 24, 2018

Stocks Post Solid Gains as Turkey Crisis Stabilizes

Stocks Post Solid Gains as Turkey Crisis Stabilizes

Stocks end Tuesday with solid gains as concerns over Turkey's currency crisis ease.

Tesla and Musk, Cigna and Icahn, Home Depot, McDonald's - 5 Things You Must Know

Tesla and Musk, Cigna and Icahn, Home Depot, McDonald's - 5 Things You Must Know

U.S. stock futures rise on Tuesday as investors cautiously return to risk markets; Home Depot reports earnings; Tesla's Elon Musk says he's working with Silver Lake Partners and Goldman Sachs as advisers on his plans to take the electric car company private.

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote "FOR" Merger Agreement With Cigna

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote "FOR" Merger Agreement With Cigna

Express Scripts Reminds Stockholders to Vote "FOR" the Merger

Long-term Cigna Shareholder Glenview Capital Submits Open Letter To Shareholders In Support Of Cigna / Express Scripts Transaction

Long-term Cigna Shareholder Glenview Capital Submits Open Letter To Shareholders In Support Of Cigna / Express Scripts Transaction

NEW YORK, Aug. 9, 2018 /PRNewswire/ -- Fellow Cigna Shareholders: Our firm, Glenview Capital Management ("Glenview"), is a 10-year investor in Cigna (NYSE:CI), and we support the Express Scripts (NASDAQ:ESRX) transaction for the following reasons: 1.

Market's Leap of Faith: Cramer's 'Mad Money' Recap (Wednesday 8/8/18)

Market's Leap of Faith: Cramer's 'Mad Money' Recap (Wednesday 8/8/18)

Jim Cramer talks about which companies and CEOs are being given the benefit of the doubt -- and which actually deserve it.

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Sometimes you gotta have faith, but you also have to be a little more skeptical.

Stocks End Higher; Tesla Surges

Stocks End Higher; Tesla Surges

Stocks ended higher Tuesday after China moved to support shares in Shanghai and on positive earnings and takeover talk.

Cigna Shreds Billionaire Carl Icahn's Critique of Express Scripts Deal

Cigna Shreds Billionaire Carl Icahn's Critique of Express Scripts Deal

Cigna argues Carl Icahn is only looking out for himself in trying to block Express Scripts deal.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

All three major indices rose Tuesday afternoon.

Jim Cramer on Apple, Alphabet, Amazon, Disney, Cigna and Express Scripts

Jim Cramer on Apple, Alphabet, Amazon, Disney, Cigna and Express Scripts

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's stocks from the floor of the New York Stock Exchange.

Jim Cramer: I Want the Cigna-Express Scripts Deal to Close

Jim Cramer: I Want the Cigna-Express Scripts Deal to Close

Activist investor Carl Icahn slammed Cigna's move to acquire Express Scripts.

Tesla's Stock Is Losing Momentum Just as the Market Nears Its All-Time Record

Tesla's Stock Is Losing Momentum Just as the Market Nears Its All-Time Record

The summer battle on Wall Street is on: Cigna vs. billionaire activist investor Carl Icahn. Stocks, meanwhile, continue to ascend to new heights despite a host of concerns.

Walt Disney, Papa John's, AT&T, Cigna, Weight Watchers - 5 Things You Must Know

Walt Disney, Papa John's, AT&T, Cigna, Weight Watchers - 5 Things You Must Know

U.S. stock futures are higher on Tuesday as earnings continue to impress; Walt Disney, Snap and Papa John's report earnings on Tuesday; the Justice Department challenges a judge's approval of the AT&T-Time Warner merger.

Express Scripts Announces New Recommendations Tackling High Drug Prices

Express Scripts Announces New Recommendations Tackling High Drug Prices

- 2019 National Preferred Formulary includes low list price medications in high-cost categories

Carl Icahn Attacks 'Cigna's $60 Billion Folly', Urges Rejection of Scripts Deal

Carl Icahn Attacks 'Cigna's $60 Billion Folly', Urges Rejection of Scripts Deal

Billionaire Investor Carl Icahn urged Cigna shareholders Tuesday to reject the company's planned acquisition of Express Scripts Holdings Co., calling the deal a "$60 billion folly".

Stocks Recover From Trade Jitters to End Mostly Higher

Stocks Recover From Trade Jitters to End Mostly Higher

After starting with a sharp selloff on the latest trade tensions with China, U.S. stocks bounced back to end mostly higher Thursday.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Nasdaq closed at its session high.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Nasdaq was the lone major U.S. index to close trading in the green Wednesday.

Express Scripts Announces 2018 Second Quarter Results

Express Scripts Announces 2018 Second Quarter Results

- Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth

TheStreet Quant Rating: B (Buy)